pubmed-article:19616500 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19616500 | lifeskim:mentions | umls-concept:C0036572 | lld:lifeskim |
pubmed-article:19616500 | lifeskim:mentions | umls-concept:C0035168 | lld:lifeskim |
pubmed-article:19616500 | lifeskim:mentions | umls-concept:C0042210 | lld:lifeskim |
pubmed-article:19616500 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
pubmed-article:19616500 | lifeskim:mentions | umls-concept:C0805701 | lld:lifeskim |
pubmed-article:19616500 | lifeskim:mentions | umls-concept:C1514307 | lld:lifeskim |
pubmed-article:19616500 | lifeskim:mentions | umls-concept:C1137111 | lld:lifeskim |
pubmed-article:19616500 | pubmed:issue | 39 | lld:pubmed |
pubmed-article:19616500 | pubmed:dateCreated | 2009-8-17 | lld:pubmed |
pubmed-article:19616500 | pubmed:abstractText | Post-licensure vaccine safety studies often monitor for seizures using automated screening of ICD-9 codes. This study assessed the positive predictive value (PPV) of ICD-9 codes used to identify seizure visits in children aged 6 weeks to 23 months who were enrolled in seven managed care organizations during January 2000 to December 2005. ICD-9 codes were used to identify visits for seizures in the 0-30-day period following receipt of a pneumococcal vaccine. Visits were stratified by setting of diagnosis (emergency department (ED), outpatient, and inpatient). Review of medical records confirmed whether the visit represented a true acute seizure event. 3233 visits for seizures were identified; 1024 were randomly selected for medical record review and 859 (84%) had records available. The PPV of ICD-9 codes was highest in the ED setting (97%), followed by the inpatient setting (64%). In the outpatient setting, computerized codes for seizures had very low PPV: 16% on days 1-30 following vaccination and 2% for visits on the same day of vaccination. An estimated 77% of true seizures identified were from the ED or inpatient settings. In conclusion, when using ICD-9 codes to identify seizure outcomes, restricting to the ED and inpatient settings of diagnosis may result in less biased preliminary analyses and more efficient vaccine safety studies. | lld:pubmed |
pubmed-article:19616500 | pubmed:language | eng | lld:pubmed |
pubmed-article:19616500 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19616500 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19616500 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19616500 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19616500 | pubmed:month | Aug | lld:pubmed |
pubmed-article:19616500 | pubmed:issn | 1873-2518 | lld:pubmed |
pubmed-article:19616500 | pubmed:author | pubmed-author:HambidgeSimon... | lld:pubmed |
pubmed-article:19616500 | pubmed:author | pubmed-author:LieuTracy ATA | lld:pubmed |
pubmed-article:19616500 | pubmed:author | pubmed-author:ShiPingP | lld:pubmed |
pubmed-article:19616500 | pubmed:author | pubmed-author:NordinJames... | lld:pubmed |
pubmed-article:19616500 | pubmed:author | pubmed-author:WeintraubEric... | lld:pubmed |
pubmed-article:19616500 | pubmed:author | pubmed-author:ShuiIrene MIM | lld:pubmed |
pubmed-article:19616500 | pubmed:author | pubmed-author:Dutta-LinnM... | lld:pubmed |
pubmed-article:19616500 | pubmed:author | pubmed-author:Vaccine... | lld:pubmed |
pubmed-article:19616500 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19616500 | pubmed:day | 27 | lld:pubmed |
pubmed-article:19616500 | pubmed:volume | 27 | lld:pubmed |
pubmed-article:19616500 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19616500 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19616500 | pubmed:pagination | 5307-12 | lld:pubmed |
pubmed-article:19616500 | pubmed:meshHeading | pubmed-meshheading:19616500... | lld:pubmed |
pubmed-article:19616500 | pubmed:meshHeading | pubmed-meshheading:19616500... | lld:pubmed |
pubmed-article:19616500 | pubmed:meshHeading | pubmed-meshheading:19616500... | lld:pubmed |
pubmed-article:19616500 | pubmed:meshHeading | pubmed-meshheading:19616500... | lld:pubmed |
pubmed-article:19616500 | pubmed:meshHeading | pubmed-meshheading:19616500... | lld:pubmed |
pubmed-article:19616500 | pubmed:meshHeading | pubmed-meshheading:19616500... | lld:pubmed |
pubmed-article:19616500 | pubmed:meshHeading | pubmed-meshheading:19616500... | lld:pubmed |
pubmed-article:19616500 | pubmed:meshHeading | pubmed-meshheading:19616500... | lld:pubmed |
pubmed-article:19616500 | pubmed:meshHeading | pubmed-meshheading:19616500... | lld:pubmed |
pubmed-article:19616500 | pubmed:meshHeading | pubmed-meshheading:19616500... | lld:pubmed |
pubmed-article:19616500 | pubmed:meshHeading | pubmed-meshheading:19616500... | lld:pubmed |
pubmed-article:19616500 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19616500 | pubmed:articleTitle | Predictive value of seizure ICD-9 codes for vaccine safety research. | lld:pubmed |
pubmed-article:19616500 | pubmed:affiliation | Department of Ambulatory Care and Prevention, Harvard Pilgrim Health Care and Harvard Medical School, Boston, MA 02215, United States. irene_shui@hphc.org | lld:pubmed |
pubmed-article:19616500 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19616500 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:19616500 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:19616500 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19616500 | lld:pubmed |